Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 104

Results For "EDS"

1318 News Found

Mental healthcare app heyy raises pre-seed funding
Startup | February 22, 2022

Mental healthcare app heyy raises pre-seed funding

US $ 555,000 invested by Wavemaker Partners in pre-seed round


Velocity Clinical Research invests in Indian tech, acquires TrierHealth
Biotech | February 22, 2022

Velocity Clinical Research invests in Indian tech, acquires TrierHealth

The investment in Indian clinical technology expertise in Hyderabad comes amid the clinical trials sector's move towards decentralised trials


Dow, Sartorius and Südpack collaborate to support global supply of coronavirus vaccines
News | February 22, 2022

Dow, Sartorius and Südpack collaborate to support global supply of coronavirus vaccines

Essential products manufactured by Sartorius, using Sü dpack polymer films made from Dow resins, support safe and effective vaccine production for global vaccine supply


SEBI approves IPO plans of PharmEasy and Wellness Forever Medicare
News | February 21, 2022

SEBI approves IPO plans of PharmEasy and Wellness Forever Medicare

The companies plan to use the proceeds to retire debt and expand operations


Syncona completes sale of Gyroscope to Novartis
News | February 20, 2022

Syncona completes sale of Gyroscope to Novartis

The transaction generates upfront cash proceeds of $442 million for Syncona's holding in Gyroscope


WHO grants prequalification of Actemra/RoActemra for critical COVID-19 patients
Drug Approval | February 20, 2022

WHO grants prequalification of Actemra/RoActemra for critical COVID-19 patients

Since the beginning of the pandemic, more than one million patients with severe COVID-19 have been treated with Actemra/RoActemra


Moderna expands Its mRNA pipeline with new development programs
Biotech | February 20, 2022

Moderna expands Its mRNA pipeline with new development programs

These programs are: Herpes simplex virus (HSV) vaccine candidate, Varicella-zoster virus (VZV) vaccine candidate and Checkpoint cancer vaccine.


Hinduja Global Solutions bags contract from the UK Health Security Agency to provide critical services
News | February 20, 2022

Hinduja Global Solutions bags contract from the UK Health Security Agency to provide critical services

The partnership is already underway having launched earlier last week, and the contract could be worth up to £211 million.


Aizon’s CEO John Vitalie named one of the top 25 Biotech CEOs of 2022
News | February 19, 2022

Aizon’s CEO John Vitalie named one of the top 25 Biotech CEOs of 2022

The Healthcare Technology Report provides market research and insights, business news, investment activity updates and important corporate developments related to the healthcare technology sector


cbdMD becomes first American CBD brand to receive UK validation
Biotech | February 19, 2022

cbdMD becomes first American CBD brand to receive UK validation

The company will now be allowed to sell its proprietary and validated tinctures, gummies, and capsules across the UK